In a recent study, an adenovirus expressing a PD1-PVR fusion protein could inhibit tumor growth mediated with CD8 + T cells in a mouse model of H22 ascites HCC, and it showed a better effect when combined with fludarabine [242]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.